These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8518540)

  • 1. Coronary microcirculation in hypertensive heart disease: functional significance and therapeutic implications.
    Motz W; Vogt M; Strauer BE
    Clin Investig; 1993; 71(5 Suppl):S42-5. PubMed ID: 8518540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of hypertensive left ventricular hypertrophy and coronary microvascular disease to calcium antagonists.
    Vogt M; Strauer BE
    Am J Cardiol; 1995 Nov; 76(13):24D-30D. PubMed ID: 7495214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation.
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S34-8. PubMed ID: 7533225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapeutic effects of antihypertensive agents on myocardium and coronary arteries in hypertension.
    Motz W; Vogt M; Scheler S; Strauer BE
    Eur Heart J; 1992 Sep; 13 Suppl D():100-6. PubMed ID: 1396852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coronary microangiopathy in hypertensive heart disease: pathogenesis, diagnosis and therapy].
    Motz W; Scheler S; Strauer BE
    Herz; 1995 Dec; 20(6):355-64. PubMed ID: 8582695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systolic ventricular dysfunction and heart failure due to coronary microangiopathy in hypertensive heart disease.
    Vogt M; Strauer BE
    Am J Cardiol; 1995 Nov; 76(13):48D-53D. PubMed ID: 7495218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention with vasoactive drugs].
    Motz W; Vogt M; Scheler S; Schwartzkopff BE; Kelm M; Strauer BE
    Z Kardiol; 1992; 81 Suppl 4():199-204. PubMed ID: 1290299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ protection: benefit from antihypertensive treatment?
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S50-4. PubMed ID: 7898094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE-inhibitors and coronary microcirculation.
    Strauer BE; Vogt M; Motz W
    Basic Res Cardiol; 1993; 88 Suppl 1():97-106. PubMed ID: 8357338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical repair of hypertensive left ventricular remodeling.
    Motz WH; Scheler S; Strauer BE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S32-6. PubMed ID: 1380616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary reserve in experimental myocardial hypertrophy.
    Gosse P; Clementy J
    Eur Heart J; 1995 Aug; 16 Suppl I():22-5. PubMed ID: 8829953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of myocardial and coronary effects of arterial hypertension].
    Strauer BE; Motz W; Vogt M
    Z Kardiol; 1989; 78 Suppl 7():231-8. PubMed ID: 2533767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure.
    Strauer BE
    Am J Cardiol; 1990 Apr; 65(14):34G-41G. PubMed ID: 2138855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Benefits and risks of hypertension therapy from the cardiac viewpoint].
    Motz W; Strauer BE
    Z Kardiol; 1994 Mar; 83(3):179-87. PubMed ID: 8178541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary reserve and arteriolosclerosis in hypertensive heart disease.
    Schwartzkopff B; Strauer BE
    Z Kardiol; 2000; 89 Suppl 9():IX/132-5. PubMed ID: 11151783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary hemodynamics in hypertensive heart disease. Basic concepts, clinical consequences, and experimental analysis of regression of hypertensive microangiopathy.
    Strauer BE
    Am J Med; 1988 Mar; 84(3A):45-54. PubMed ID: 2975465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the coronary circulation in hypertension.
    Strauer BE; Schwartzkopff B; Kelm M
    J Hypertens; 1998 Sep; 16(9):1221-33. PubMed ID: 9746107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular hypertrophy and coronary microcirculation in hypertensive heart disease.
    Strauer BE; Schwartzkopff B
    Blood Press Suppl; 1997; 2():6-12. PubMed ID: 9495619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heart, macrocirculation and microcirculation in hypertension: a unifying hypothesis.
    Struijker Boudier HA; Cohuet GM; Baumann M; Safar ME
    J Hypertens Suppl; 2003 Jun; 21(3):S19-23. PubMed ID: 12929471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.